MARY WELBORN: Open Payments
NPI 1245960350 · WEST BURLINGTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$220 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $173 · 2025 $220
Food & beverage: $220
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $47 |
| Novo Nordisk Inc | 2 | $42 |
| Alkermes, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
Products named: Ozempic, ARISTADA, CAPLYTA, PREVNAR 20, NURTEC ODT, Kerendia, JOURNAVX, UBRELVY.
Industry payments across IA — which companies pay providers there.
